Human alveolar macrophages release chemotactic activity for neutrophils, prodding a role for alveolar macrophages in regulating inflammation in the lung. As alveolar macrophages produce large amounts of leukotriene B4 (LTB4), a chemotactically active lipoxygenase product of arachidonic acid, we investigated the contribution of LTB4 to the total neutrophil chemotactic activity produced by these cells. Normal human alveolar macrophages were recovered by bronchoalveolar lavage from healthy volunteers and incubated either with the calcium ionophore A23187 for 1 h, or with opsonized zymosan particles or latex beads for 3 h. Nordihydroguaretic acid (NDGA), a relatively specific lipoxygenase inhibitor, blocked the release of neutrophil chemotactic activity after all three stimuli in a dose-dependent manner. This correlated with blockade of LTB4 production as measured by high performance liquid chromatography using freshly isolated alveolar macrophages, as well as blockade of I3H]LTB4 production by macrophages prelabeled with [Hjarachidonate. Molecular sieve chromatography using Sephadex G-50 confirmed that essentially all of the chemotactic activity in the stimulated macrophage supernatants co-eluted with authentic I3HILTB4, and that NDGA completely blocked the chemotactic activity in the eluting fractions. Readdition of authentic LTB4 (1 X iO-7 M) to the NDGA-blocked macrophage supernatants restored the chemotactic activity in the supernatants. The macrophage supernatants did not contain platelet-activating factor-like activity, as measured by the stimulation of V3Hlserotonin release from rabbit platelets, and by high performance liquid chromatography. NDGA did not change the protein-secretion profiles of fresh alveolar macrophages, or of macrophages prelabeled with 135Simethionine. The complement (C) components C5ad.,.z were not detected in any of the supernatants by radioimmunoassay. Concentration of the supernatants by positive pressure filtration (5,000-D membrane) did not augment chemotactic activity in the stimulated supernatants or uncover chemotactic activity in the NDGA-blocked supernatants. As with the 3-h studies, when alveolar macrophages were incubated overnight with opsonized zymosan, all of the increase in chemotactic activity could also be blocked by NDGA. These data indicate that LTB4 is the predominant neutrophil chemotactic factor secreted by the normal resident human alveolar
Introduction
The alveolar macrophage (AM)' plays an important role in the defense of the conducting airways and alveolar membrane against particulates that elude the physical barriers of the upper airway. It is unlikely, however, that AM function as solo defenders of the alveolar spaces, because compared with other phagocytes, AM migrate sluggishly in response to chemotactic stimuli, and kill microorganisms slowly. Rather, a more important function of the resident AM may be the initiation and amplification of inflammatory responses in the lung via the secretion of chemotaxins that recruit effector cells to the lung (1-3).
The first demonstration that AM release chemotactic activity for blood neutrophils followed the observation that repeated bronchoalveolar lavage of primate lungs led to the accumulation of neutrophils in bronchoalveolar lavage fluid (1) . The bronchoalveolar lavage fluid contained two identifiable chemotactic factors, the larger ofwhich was thought to be C5a, as its apparent molecular weight was 15 ,000 and its activity was inhibitable by anti-C5 antibodies. The smaller factor had an apparent molecular weight of -5,000 and was not inhibited by anti-C5 antibodies. It was detected in both concentrated lavage fluid and concentrated supernatants of AM monolayers incubated in vitro. This factor was released from primate AM stimulated by adherence to glass or by phagocytosis of opsonized, heat-killed staphylococci (1) .
Human AM have also been shown to produce neutrophil chemotactic activity but there is conflicting evidence about the nature of the chemotactic substance(s) (2, 3) . Merrill and associates (2) described two chemotactic substances in concentrated supernatants of human AM from nonsmoking subjects. The larger factor (apparent molecular weight of 10,000) was trypsin sensitive and appeared to be distinct from C5 or C3a, as its apparent activity was not inhibited by antisera to these complement (C) fragments. Isoelectric focusing ofthe concentrated larger factor revealed five separate fractions, of which only one had significant chemotactic activity (pI = 5.0). The smaller chemotactic factor (apparent molecular weight < 1,000) was not characterized. Hunninghake and associates (3) found that human AM stimulated with immune complexes or particulates produce a low molecular weight (400-600) chemotactic factor that was insensitive to a variety of proteases. It was 80% extractable into lipid solvents, which suggested that this factor might be lipid derived, but analysis by gas chromatography and mass spectroscopy suggested that it was not a monohydroxyeicosatetraenoic acid (HETE). A similar low molecular weight chemotactic factor also is produced by guinea pig AM (4, 5) .
One of the most active lipid-derived chemotactic substances is leukotriene B4 (LTB4), a 5-lipoxygenase product of arachidonic acid metabolism produced by polymorphonuclear and mononuclear phagocytes (6) . Arachidonic acid constitutes nearly 20% of the membrane lipid of rabbit AM (7) , and human blood monocytes (8) and human AM release large amounts of LTB4 after stimulation with either soluble or particulate stimuli (9-1 1) . Evidence from rabbit AM suggests that LTB4 may account for a large part of the chemotactic activity produced by these cells, as blockade of the lipoxygenase pathway abolishes the release of neutrophil chemotactic activity after particulate stimuli (12) .
As LTB4 has many features in common with the previously described low molecular weight neutrophil chemotactic factor produced by AM, the goal of this study was to determine the relative contribution of LTB4 to the neutrophil chemotactic activity produced by the resident human AM.
Methods
Special reagents. Synthetic LTB4, 20-COOH-LTB4, 20-OH-LTB4, LTC4, LTD4, and LTE4, and 54S), 12 -(S)-di-HETE were kindly provided by Dr. J. Rokach, Merck Frosst Laboratories, Pointe-Claire, Dorval, Quebec. The HETE standards (5-HETE, 8-HETE, 9-HETE, I -HETE, 12-HETE, and 15-HETE) were provided by Dr. W. C.
Hubbard, National Institutes of Health, Bethesda, MD. 54S), 12 -R)-dihydroxy-6,8, I 0-trans-14-cis-eicosatetraenoic acid (abbreviated 54S), 124R)-6-trans-LTB4) and 54S), 124S)-dihydroxy-6,8, l0-trans-14-cis-eicosatetraenoic acid (abbreviated 54S),124S)-6-trans-LTB4) were purified from neutrophils stimulated by the calcium ionophore A23187 as previously described (13) . [5,6,8,9,11,12,14,15-3H (N) Arachidonic acid (60-100 Ci/mmol), 14,15-[3H(N)]LTB4 Ci/ mmol), l-O4alkyl-1,2-3H), alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (platelet-activating factor [PAF]) (30-60 Ci/mmol), and [3H]-acetic acid, sodium salt (500 mCi/mmol) were obtained from New England Nuclear, Boston, MA. The calcium ionophore A23187 was obtained from Calbiochem-Behring Corp. La Jolla, CA.
Cell recovery. AM were recovered as previously described from the lungs of 23 healthy volunteers who gave written informed consent (1 1). All were free of respiratory diseases and none used cigarettes or medications of any kind. Briefly, subsegments of the right middle lobe and the lingula each were lavaged five times with 50-ml aliquots of sterile, pyrogen-free 0.89% NaCl (total volume, 250 ml in each site) using a flexible fiberoptic Olympus BF-3 bronchoscope. The procedure was well tolerated, as determined by a direct questioning of each volunteer by telephone during the evening after the procedure. The lavage fluid was recovered with gentle suction, pooled, filtered through moist gauze to remove mucus, and centrifuged at 600 g for 15 min at 4VC to pellet the cells. The Preparation ofstimulated macrophage supernatants. To stimulate the release of neutrophil chemotactic activity, the macrophages were incubated at 2.5 X 106/ml in either HBSS or Tyrode's buffer in rotating tubes (to minimize adherence) at 370C in 5% C02/air for 1 h with the calcium ionophore A23187 (10 ug/ml) (Calbiochem-Behring Corp.), or for 3 h with one of two different particulate stimuli, opsonized zymosan particles (OZ) (2 X 108/ml) (Sigma Chemical Co., St. Louis, MO), or opsonized latex beads (LB) (2 X 108/ml) (Sigma Chemical Co.). The OZ were boiled and washed extensively before use. To facilitate phagocytosis, the particulate stimuli were preopsonized by incubation for I h at 370C with 50% fresh human serum. They were then washed extensively and stored frozen at -70'C. In some experiments, nordihydroguaretic acid (NDGA), or diethylcarbamazine (DEC) were added at least 5 min before adding the stimuli to block the lipoxygenase pathway of archidonic acid metabolism. To confirm the findings with opsonized zymosan and latex beads, additional experiments were performed using opsonized Staphylococcus aureus, 502a. The S. aureus were grown overnight in trypticase soy broth, washed, resuspended to an optical density of 0.2 at 540 nm, and added to human AM in Tyrode's buffer containing 5% autologous human serum as an opsonin. To test the effects of a longer incubation period in a more complete medium, we performed additional experiments in which AM were incubated overnight in tissue culture media (RPMI 1640, Gibco) containing 0.5% bovine serum albumin with or without OZ and NDGA.
After each incubation, cell viability was measured by trypan blue exclusion and, for particulate stimuli, the number of cells with cell-associated particles was counted by light microscopy. The cell suspensions were centrifuged at 600 g for 15 min at 4°C and the supernatants were decanted, filtered (0.22-Am filters, Millipore Corp., Bedford, MA), and stored at -70°C until assayed. The neutrophil chemotactic activity in each supernatant was measured within 3 wk. In some experiments the supernatants were concentrated before assay by positive pressure filtration under nitrogen at 4°C using a membrane with a 5,000 mol wt limit (YM-5; Amicon Corp., Danvers, MA).
Chemotaxis assay. The chemotaxis of normal human peripheral blood neutrophils toward the AM supernatants was measured in microchemotaxis chambers using nitrocellulose membranes with 3.0-,gm-sized pores (11, 14) . Neutrophils were obtained from the peripheral blood of healthy volunteers by Ficoll-Hypaque density gradient centrifugation, followed by dextran sedimentation and hypotonic lysis of residual erythrocytes (15) . A different donor was used for each separate experiment. The neutrophils were washed and resuspended in Gey's balanced salt solution (Gibco) at a final concentration of 1.0 X 106/ml. 25 ul of the undiluted macrophage supernatant was added to each lower well of the microchemotaxis chambers and 50 M1 of cells were added to each upper well. After incubation for 2 h in 5% C02/air, the membranes were removed, stained with Dif-Quik, and mounted on microscope slides. Chemotaxis was measured with a 1.0-mm2 eyepiece grid as the total number of cells that migrated through each filter (within the grid) in 10 consecutive light microscopic fields (X 540). In each experiment, the chemotactic activity in each supernatant was tested in quadruplicate wells and the results were averaged.
Molecular sieve chromatography. To determine the apparent molecular weight of the chemotactic activity in the AM supernatants, the supernatants were applied to a 1 X 51-cm Sephadex column (G-50 fine; Pharmacia Fine Chemicals; Piscataway, NJ) and eluted with 0.05 M NH4HCO3 buffer, pH 7.2, at a flow rate of 8.2 ml/h at 4°C. The optical density ofthe eluate was measured continuously at 280 nm and 2.0-ml fractions were collected and assayed for neutrophil chemotactic activity. or Tyrode's solution at 2.5 X 106 viable cells/ml, and stimulated as described. The uptake of [3H]arachidonic acid was determined using scintillation counting by comparing the number of counts in the cell pellets after lysis with 0.1% Triton-X (New England Nuclear) with the total number of counts in each tube (supernatant plus pellet). The release of radiolabeled arachidonic acid products was measured by comparing the number of counts in each supernatant with the total number of counts in each tube (supernatant plus pellet).
The lipoxygenase products of arachidonic acid were measured in each supernatant by high performance liquid chromatography (HPLC) as previously described (11), Briefly, the supernatants were prepared for HPLC by initial solid-phase extraction. using octadecyl Baker-1O columns (J. T. Baker Chemical Co., Phillipsburg, NJ) followed by evaporation to dryness and reconstitution in methanol. After centrifugation at 3,000 g for 5 min at 4VC, the samples underwent reversephase HPLC on a 4.6 X 250-mm Ultrasphere ODS C18 column (5 tm particle size, Beckman Instruments, Inc., Berkeley, CA) using methanol/water/acetic acid (75:25:0.01, vol/vol/vol), pH 4.7, at a flow rate of 1 ml/min (HPLC condition I). Peaks at 280 and 235 nm that co-eluted with authentic leukotriene and HETE standards were collected and rechromatographed on a 4.6 X 75-mm Ultrasphere ODS Cj8 column (3Mum particle size, Beckman Instruments, Inc.) using the same solvent at a flow rate of 1. by reverse-phase HPLC, the peaks collected at the retention time of these compounds were converted to their methyl esters with excess diazomethane in diethyl ether and resolved by straight-phase HPLC on a IMPorasil column (3.9 X 300 mm, 10Mum particle size, Waters Assoc., Milford, MA), as previously described (9) . Using hexane/isopropanol/ acetic acid (95:5:0.01, vol/vol/vol) at a flow rate of 1 ml/min (HPLC condition III), the retention times of 54S), 124S)-diHETE and LTB4 methyl ester standards were 16.7-18.4 min and 23.8-26.0 min, respectively. The ultraviolet spectra of the rechromatographed peaks were measured using a recording spectrophotometer (model 219; Cary Instruments, Monrovia, CA) and the amount of each compound was calculated using the extinction coefficient for each identified arachidonate metabolite as previously described (12) .
In some experiments, LTB4 in AM supernatants was assayed by the Proteins, To determine whether the various stimuli might affect protein secretion by the AM and whether NDGA also might block the secretion of these proteins, we analyzed the supernatants for total protein and protein profiles. Total proteins were measured by the Lowry method (22) in an assay modified for microtiter plates (23) . To measure the release of preformed proteins from the macrophages, aliquots of the supernatants were dissolved in Laemmli sample buffer (24) and analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) in continuous gradients (10-20 or 5-15% acrylamide) with and without ,B-mercaptoethanol as a reducing agent.
The gels were stained with either a silver stain method (25) or with Coomassie Blue. Molecular weight standards were purchased from Pharmacia Fine Chemicals.
To measure the release of newly synthesized proteins, human AM were incubated in methionine-deficient Dulbecco's modified Eagle's medium (Gibco) supplemented with L-glutamine (584 Mg/ml), penicillin (100 U/ml), streptomycin (100 Mg/ml), and bovine serum albumin (1 mg/ml), for i h at 37°C in 5% C02/air. The cells were sedi- gentle agitation. After labeling, the cells were washed, resuspended in HBSS, and stimulated as described above. These supernatants were analyzed by SDS-PAGE as described, and the gels were stained with Coomassie Blue to idenify the position of the molecular weight standards, then impregnated with Enhance (New England Nuclear), dried, placed on Kodak X-Omat AR film, and exposed at -70°C for 14 d.
To determine whether the chemotactically active C fragments C5a or COad., might account for a portion of the chemotactic activity in the supernatants, we tested each supernatant for these products by radioimmunoassay as previously described (26) (27) . A P value of 0.05 or less was accepted as significant.
Results
Release ofchemotactic activity. Stimulation of normal human AM with the calcium ionophore A23 187, OZ, and LB caused the release of neutrophil chemotactic activity into the macrophage supernatants (Fig. 1) . The ionophore caused the greatest release of chemotactic activity (-250 polymorphonuclear neutrophilic leukocytes [PMN]/10 high-power fields [HPF]), and this was nearly twofold greater than that induced by either OZ or LB. OZ and LB caused the release of equivalent amounts of chemotactic activity, despite the fact that the macrophages appeared to ingest approximately five times more LB than OZ, by light microscopy.
The addition ofNDGA (l0-5-l0-' M) inhibited the release of neutrophil chemotactic activity in a dose-dependent fashion from both ionophore-and particle-stimulated macrophages (Fig. 1) . The NDGA did not affect macrophage viability as measured by trypan blue exclusion or the number of cells that ingested particles. Similar results were obtained using S.
aureus as the particulate stimulus. As with OZ and LB, NDGA (i0-4 M) inhibited 100% ofthe neutrophil chemotactic activity in the supernatants ofAM incubated with S. aureus (P < 0.05).
These results were not unique to NDGA, as DEC (10-3 M) also inhibited the generation of neutrophil chemotactic activity in response to OZ by > 90%. Control experiments established that NDGA and DEC at the concentrations used did not inhibit neutrophil chemotaxis toward either LTB4 (10-7 M) or zymosan-activated serum.
Molecular sieve chromatography. To estimate the apparent molecular weight of the neutrophil chemotactic activity, and to determine whether any chemotactic activity was associated with the protein-containing fractions of the supernatants, particularly those in the 10-15 kD range as had been previously suggested (2), we performed molecular sieve chromatography using Sephadex G-50 to analyze the supernatants of AM from three separate volunteers. The chemotactic activity in the ionophore-and particulate-stimulated supernatants eluted in late fractions (tubes 34 to 38) with a retention time corresponding to that of synthetic [3H]LTB4 (Figs. 2 A and 3 A) . No chemotactic activity was present in the protein-containing fractions of either A23187 or zymosan-stimulated macrophages. Authentic 3H-PAF consistently eluted 3 to 4 tubes earlier than either [3H]LTB4 or the chemotactic activity. When [3HJLTB4 and 3H-PAF where applied simultaneously to the column, twin peaks of radioactivity were observed, with 3H-PAF eluting four tubes earlier than [3H]LTB4, indicating that the retention time of the chemotactic activity is similar to that of LTB4 and distinct from that of PAF. In the supernatants of the NDGA-treated macrophages, the chemotactic activity in the late fractions (tubes 34 to 38) was almost completely abolished for both the A23187 and the zymosan-stimulated macrophages (Figs. 2 B and 3 B) . (Fig. 4) (Fig. 4) . At lower concentrations (l0-5 M), NDGA blocked predominantly LTB4 and HETE production, whereas at higher concentrations (10-4 M), NDGA also partially blocked the early eluting peaks (4-8) min) that represent predominantly cyclooxygenase products. The detection of LTB4 by HPLC was not affected by the presence of NDGA. In two separate experiments using AM from two different human subjects, NDGA (10-' M) also significantly reduced the production of LTB4 by S. aureus-treated AM, as detected by radioimmunoassay (18.3±8.0 ng LTB4/ 106 cells without NDGA vs. 0.2±0.1 ng LTB4/ 106 cells with NDGA). For all of the macrophage stimuli, the reduction in neutrophil chemotactic activity in the presence of NDGA paralleled the reduction in the amounts of LTB4 detected in the supernatants.
To determine whether the reduction in chemotactic activity in the presence of NDGA could be accounted for by the reduction in LTB4 concentration in the supernatants, we performed add-back experiments in which known amounts of LTB4 were added to supernatants generated in the presence of NDGA (l0-4 M) ( Table I ). The addition of LTB4 to these supernatants increased the amount of neutrophil chemotactic activity in a dose-dependent manner. At a concentration of LTB4 that approximated that found in the original supernatants (5 X l0-' M), the chemotactic activity of the original supernatant was almost entirely restored.
PAF. Fig. 5 shows that zymosan-stimulated and -unstimulated macrophage supernatants from three separate human volunteers failed to cause the release of significant amounts of
[3H]serotonin from rabbit platelets. To be certain that potential PAF activity in the macrophage supernatants was not blocked by an inhibitor in the supernatants, we added authentic PAF to each ofthe zymosan-stimulated and NDGA-treated but the particulate stimuli caused little additional release of proteins into the unconcentrated supernatants (Fig. 6) . Although the addition of NDGA tended to reduce the protein secretion partially for each of the stimuli tested, none of the apparent reductions in protein secretion were statistically significant when compared with the respective stimulated values.
Analysis of the supernatants of unlabeled and [3"S]-methionine labeled macrophages by SDS-PAGE and autofluorography showed that the types of proteins secreted were similar in the stimulated and the NDGA-blocked supernatants (Fig. 7) . The NDGA did not affect the pattern of release of either preformed or metabolically labeled proteins in response to either A23187 or OZ, particularly those with a <43,000 mol wt.
To determine whether the macrophage supernatants might contain one or more chemotactically active proteins in low concentration, we incubated AM from two different volunteers with A23187 with or without added NDGA, then combined the supernatants to increase the starting volume, and concentrated them approximately five-to sixfold by positive pressure filtration at 4°C under nitrogen. The resulting fluids were tested twice for chemotactic activity and the results are shown in Table II . The concentration procedure did not augment the neutrophil chemotactic activity in the A23187-stimulated supernatant. The chemotactic activity in the proteinfree filtrate was similar to that of the protein-enriched concentrate, indicating that the chemotactic activity distributes relatively evenly across this type of membrane (5,000 mol wt limit). In addition, concentrating the NGDA-blocked supernatant in a similar fashion did not increase the neutrophil chemotactic activity in that supernatant.
As macrophages have been reported to secrete complement components (29) , we analyzed the stimulated macrophage supernatants for the presence of CSa and C5adg, by radioimmunoassay to determine whether these proteins might account for some of the chemotactic activity in the unconcentrated supernatants. However, none of the supernatants contained detectable amounts of CSa or C5ad.8, indicating that these compounds were not present at concentrations detectable in this assay (-8.0 X 10-12 M). As CSa is chemotactically active 600- at concentrations > 10-10 M, C5 fragments could not account for the chemotactic activity in the unconcentrated macrophage supernatants. Studies with cultured macrophages. In additional experiments, AM were incubated overnight in complete tissue culture media with or without OZ and NDGA to determine the effects of lipoxygenase blockade on neutrophil chemoactic activity liberated under these circumstances. The AM incubated alone for 24 h released detectable but small amounts of neutrophil chemotactic activity into the supernatants (Fig. 8) . As with the 3-h experiments, NDGA blocked the increase in neutrophil chemotactic activity from AM incubated with OZ. The NDGA (at 10-4 M) did not block the basal secretion of small amounts of neutrophil chemotactic activity by the macrophages. The amount of chemotactic activity in these uncon- The additional experiments that we pefformed using AM incubated overnight indicate that under these conditions also, LTB4 is likely to be the predominant neutrophil chemoattractant released. The NDGA blocked the increase in chemotactic activity caused by phagocytosis of OZ and this correlated with blockade of LTB4 release. The persistent background chemotactic activity in these supernatants, however, leaves open the possibility that these supernatants also contain small amounts of another chemoattractant, e.g., the larger molecular weight species described by Merrill and associates in the 10-fold concentrated supernatants of normal AM incubated for 24 h in tissue culture media (2) .
PAF is another low molecular weight lipid product that is produced by both mononuclear and polymorphonuclear phagocytes, and is chemotactically active for neutrophils and monocytes, as is LTB4 (17, 18, (36) (37) (38) (39) . In rat AM, PAF is formed by the actions of phospholipase A2 and acetyl transferase on membrane phospholipids, in the same sequence of reactions that leads to the release of arachidonic acid (40, 41) . The observation that the supernatants of ionophore-stimulated human AM cause platelet aggregation (42) suggested that these cells also produce PAF, and raised the possibility that PAF release might account for some of the chemotactic activity in these stimulated macrophage supernatants.
Our results suggest that PAF does not account for the neutrophil chemotactic activity that we observed for several reasons. First, the molecular sieve chromatography data indicate that the chemotactic activity produced by ionophore-and zymosan-stimulated macrophages eluted later than PAF. Authentic PAF consistently eluted at least four tubes earlier than both authentic LTB4 and the peak of the chemotactic activity.
When authentic 3H-PAF and [3H]LTB4 were mixed and added to the Sephadex G-50 column, twin peaks were recovered at the locations corresponding to those observed when each was added separately. Second, PAF was not recovered by HPLC from the supernatants of ionophore-stimulated AM. Third, supernatants of zymosan-stimulated macrophages that contained neutrophil chemotactic activity did not cause the release of [3H]serotonin from rabbit platelets, which is a sensitive bioassay for PAF activity (18) . When authentic PAF was added to these supernatants, the expected amount of [3H]-serotonin release occurred, indicating that the supernatants did not contain a macrophage product that blocked PAF-induced serotonin release. Fourth, we were unable to reconstitute the chemotactic activity in the NDGA-blocked supernatants by the addition of authentic PAF (1.0 X l0-7 M).
In summary, the data indicate that LTB4 is the predominant neutrophil chemoattractant produced by the normal human AM in response to calcium flux across the cell membrane and the phagocytosis of opsonized particulates. Our findings are limited to normal AM, as we obtained macrophages from humans without chronic inflammatory lung diseases and we did not study the effects of immunologic activation. It is possible that when AM are activated, the profile of chemoattractants produced changes and that under these conditions, protein or peptide chemoattractant(s) might be more important (2) . Further studies are warranted with activated AM derived from patients with chronic immunologic lung diseases and with AM activated in vitro with different immunologic stimuli, e.g., y-interferon or other lymphokines (43) .
The finding that normal resident AM secrete large amounts of LTB4 suggests that these cells may play an important role in the initiation and the amplification of inflammatory processes in response to inhaled stimuli, by recruiting neutrophils and monocyte-macrophages into the lung. The finding that LTB4 also is a chemoattractant for fibroblasts suggests a role for this AM-derived product in fibrotic responses as well (44) . As LTB4 appears to be the major neutrophil chemoattractant elaborated by normal resident human AM, pharmacologic modulation of its release might help to limit some types of inflammatory reactions in the lungs.
